GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (NAS:ORKA) » Definitions » Change In Other Working Capital

ORKA (Oruka Therapeutics) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Oruka Therapeutics Change In Other Working Capital?

Oruka Therapeutics's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Oruka Therapeutics's Other Working Capital stayed the same from . 20 to Dec. 2024 .

Oruka Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Oruka Therapeutics's Other Working Capital stayed the same from . 20 to Dec. 2024 .

Oruka Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Oruka Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oruka Therapeutics Change In Other Working Capital Chart

Oruka Therapeutics Annual Data
Trend Dec24
Change In Other Working Capital
-

Oruka Therapeutics Semi-Annual Data
Dec24
Change In Other Working Capital -

Oruka Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oruka Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Oruka Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Oruka Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oruka Therapeutics Inc (NAS:ORKA) » Definitions » Change In Other Working Capital
Comparable Companies
MGTX AUTL SEPN DNA SAGE ATAI MBX PGEN TECX CYDY VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
HQ1:Germany
Address
855 Oak Grove Avenue, Suite 100, Menlo Park, CA, USA, 94025
Website
https://www.orukatx.com
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.